Eyegate Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eyegate Pharmaceuticals Inc
CIK #0001372514
EDGAR Form CIK 2011 - 2025
10-K [0001372514]
10-Q [0001372514]
3 [0001372514]
4 [0001372514]
8-K [0001372514]
D [0001372514]
SC 13D [0001372514]
SC 13G [0001372514]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Partners Limited Partnership Kiora Pharmaceuticals Inc [2025-08-14]
Adar1 Capital Management LLC Kiora Pharmaceuticals Inc [2024-11-14]
Alyeska Investment Group LP Kiora Pharmaceuticals Inc [2024-11-14]
Nantahala Capital Management LLC Kiora Pharmaceuticals Inc [2024-11-14]
Goldman Sachs Group Inc Kiora Pharmaceuticals Inc [2024-11-12]
Rosalind Advisors Inc Kiora Pharmaceuticals Inc [2024-05-29]
Rosalind Advisors Inc Kiora Pharmaceuticals Inc [2024-05-29]
Stonepine Capital Management LLC Kiora Pharmaceuticals Inc [2024-02-09]
Hirschman Orin Kiora Pharmaceuticals Inc [2024-02-07]
Lind Global Fund II LP Kiora Pharmaceuticals Inc [2023-06-13]
View All
Form 3/4/5 Subject 2011 - 2025
Tosca Melissa
Kiora Pharmaceuticals Inc
Walters-Hoffert Lisa
Stengone Carmine N.
Tyle Praveen
Hollander David
Parsons Erin
Shapiro Aron
Strem Brian M.
Daniels Eric Joseph
View All
Terms | Privacy | Guide
tony@aum13f.com